Godavari Biorefineries Limited secured a patent from the European Patent Office for its invention titled “Pharmaceutical Composition and a Process to Prepare the Same.” The patent covers a pharmaceutical composition that combines novel anti-cancer compounds with a solubilising agent, along with the process used to prepare it. The company said the development strengthens its oncology-focused intellectual property portfolio and expands its presence in international markets.
Patent Targets Drug Solubility and Bioavailability
The patented pharmaceutical composition is designed to improve the solubility and bioavailability of its active compounds. As a result, the formulation could support the therapeutic development of these compounds. The invention has potential applications in the treatment of various cancers, including breast and prostate cancers. In particular, the composition is intended for potential use through oral administration. By addressing formulation challenges associated with active pharmaceutical compounds, the invention aims to support their development for therapeutic applications.
Focus on Oncology Research
Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries Limited, said the formulation of a promising compound plays an important role in its development for therapeutic use. She added that the company’s research has focused on improving the solubility and bioavailability of these compounds. According to her, the European patent grant recognises this research and represents an important milestone for the company’s oncology-focused innovation.
Expanding International Intellectual Property
Samir Somaiya, Chairman and Managing Director, Godavari Biorefineries Limited, said the company’s innovation strategy focuses on advancing health, wellbeing and sustainability while creating long-term value. He highlighted the company’s investments in research and development as it expands beyond its traditional businesses and builds capabilities in areas where science and technology can address societal needs. Furthermore, he mentioned that the European patent strengthens Godavari Biorefineries’ intellectual property portfolio and could support the development of solutions with potential healthcare applications.
Strengthening Global R&D Capabilities
The European patent further expands Godavari Biorefineries’ international intellectual property footprint. The company continues to protect its research and innovations across major global markets. As per the press release, with its focus on research and development, Godavari Biorefineries is building capabilities in healthcare and other technology-driven areas while seeking opportunities to create sustainable business value and contribute to societal needs.
